These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 10459899)

  • 1. Trials stopped early: too good to be true?
    Pocock S; White I
    Lancet; 1999 Mar; 353(9157):943-4. PubMed ID: 10459899
    [No Abstract]   [Full Text] [Related]  

  • 2. Getting a handle on posttransplant recurrence of HCC.
    de Vera ME
    Oncology (Williston Park); 2009 Dec; 23(14):1287, 1291. PubMed ID: 20120842
    [No Abstract]   [Full Text] [Related]  

  • 3. [Liver transplantation for hepatocellular carcinoma].
    Tanaka A; Tanaka K; Kaihara S; Ueda M; Uemoto S; Kiuchi T; Egawa H
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():705-16. PubMed ID: 11762042
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of recurrent hepatocellular carcinoma after liver transplantation.
    Davis E; Wiesner R; Valdecasas J; Kita Y; Rossi M; Schwartz M
    Liver Transpl; 2011 Oct; 17 Suppl 2():S162-6. PubMed ID: 21688382
    [No Abstract]   [Full Text] [Related]  

  • 5. Adjuvant iodine-131-labeled lipiodol for prevention of intrahepatic recurrence of hepatocellular carcinoma: which is the best treatment schedule?
    Tabone M; Vigano L; Laudi C; Ferrero A; Pellerito R; Capussotti L
    Hepatology; 2005 Jun; 41(6):1433; author reply 1433-4. PubMed ID: 15834934
    [No Abstract]   [Full Text] [Related]  

  • 6. Is postoperative chemotherapy effective for the prevention of recurrence after surgery for hepatocellular carcinoma?
    Kanmematsu T
    Hepatogastroenterology; 1996; 43(12):1404. PubMed ID: 8975938
    [No Abstract]   [Full Text] [Related]  

  • 7. Adjuvant treatment after orthotopic liver transplantation: is it really necessary?
    Kim R; Tan A; Estfan B; Aucejo F
    Oncology (Williston Park); 2009 Dec; 23(14):1276-81. PubMed ID: 20120841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant systemic drug therapy and recurrence of hepatocellular carcinoma following curative resection.
    Zhong Y; Liu B; Deng M; Xu R
    Drug Discov Ther; 2013 Aug; 7(4):164-6. PubMed ID: 24071579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TAILORx: trial assigning individualized options for treatment (Rx).
    Sparano JA
    Clin Breast Cancer; 2006 Oct; 7(4):347-50. PubMed ID: 17092406
    [No Abstract]   [Full Text] [Related]  

  • 10. Tools for monitoring patients with hepatocellular carcinoma on the waiting list and after liver transplantation.
    Kneteman N; Livraghi T; Madoff D; de Santibañez E; Kew M
    Liver Transpl; 2011 Oct; 17 Suppl 2():S117-27. PubMed ID: 21584926
    [No Abstract]   [Full Text] [Related]  

  • 11. Design and endpoints of clinical trials in hepatocellular carcinoma.
    Llovet JM; Di Bisceglie AM; Bruix J; Kramer BS; Lencioni R; Zhu AX; Sherman M; Schwartz M; Lotze M; Talwalkar J; Gores GJ;
    J Natl Cancer Inst; 2008 May; 100(10):698-711. PubMed ID: 18477802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical trials of note. Sorafenib as adjuvant treatment in the prevention of disease recurrence in patients with hepatocellular carcinoma (HCC) (STORM).
    Printz C
    Cancer; 2009 Oct; 115(20):4646. PubMed ID: 19806596
    [No Abstract]   [Full Text] [Related]  

  • 13. [Liver transplantation for hepatocellular carcinoma].
    Decaens T; Hurtova M; Duvoux C
    Gastroenterol Clin Biol; 2009 Jan; 33(1 Pt 1):61-9. PubMed ID: 19108968
    [No Abstract]   [Full Text] [Related]  

  • 14. Should the liver transplant criteria for hepatocellular carcinoma be different for deceased donation and living donation?
    Grant D; Fisher RA; Abecassis M; McCaughan G; Wright L; Fan ST
    Liver Transpl; 2011 Oct; 17 Suppl 2():S133-8. PubMed ID: 21634006
    [No Abstract]   [Full Text] [Related]  

  • 15. Ethics of clinical trials from bayesian perspective: medical decision making should use posteriors, not priors.
    Frankel S; Sterne J; Ebrahim S
    BMJ; 2003 Jun; 326(7404):1456. PubMed ID: 12829563
    [No Abstract]   [Full Text] [Related]  

  • 16. [Strategy to improve the prognosis of liver transplantation for hepatocellular carcinoma].
    Fan J; Xu Y
    Zhonghua Wai Ke Za Zhi; 2008 Nov; 46(21):1602-5. PubMed ID: 19094749
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical research in hepatocellular carcinoma: study design and endpoints.
    Forner A; Roayaie S
    J Hepatol; 2009 May; 50(5):850-3. PubMed ID: 19329214
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of hepatocellular carcinoma: hepatic resection and liver transplantation].
    Cenuşă A
    Rev Med Chir Soc Med Nat Iasi; 2005; 109(4):709-12. PubMed ID: 16610164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatectomy versus radiofrequency ablation for early hepatocellular carcinoma.
    Fujita T
    J Hepatol; 2009 May; 50(5):1051-2; author reply 1052-3. PubMed ID: 19329216
    [No Abstract]   [Full Text] [Related]  

  • 20. Adjuvant therapy with capecitabine postpones recurrence of hepatocellular carcinoma after curative resection: a randomized controlled trial.
    Xia Y; Qiu Y; Li J; Shi L; Wang K; Xi T; Shen F; Yan Z; Wu M
    Ann Surg Oncol; 2010 Dec; 17(12):3137-44. PubMed ID: 20602260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.